Mark O’Donnell Joins Argonaut Manufacturing Services Board Carlsbad, CA, Nov 05, 2019 – Argonaut Manufacturing Services announced today that Mark O’Donnell has been appointed to
CHARLOTTE, N.C. — Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, has acquired Medpricer, one of the nation’s leading technology-based solutions, to optimize healthcare provider
Vancouver BC, Oct 09, 2019 (GLOBE NEWSWIRE) — Precision NanoSystems (PNI) a global leader of innovative solutions for the discovery, development, and manufacture of nanomedicine
The Therapeutic Antibody Revolution in the Post Genomics Era: Using High Throughput SPR to Explore the Full Kinetic and Epitope Diversity of Antibody Libraries Supporting
Bradenton, Fla .—Centerstone, a national leader in behavioral health care, has started using new and highly-effective patient safety technology for patients in its care on
MENLO PARK, CA — July 18, 2019 — Akoya Biosciences, Inc., The Spatial Biology Company™, announced today that an in-depth comparison of immuno-oncology biomarker types
San Diego, June 4, 2019—Verogen announced today that its DNA sequencing technology played a pivotal role in a recent court case in the Netherlands. This marks
San Diego, May 8, 2019—Cellmark Forensic Services and Verogen have signed a collaboration agreement to establish Cellmark as a United Kingdom (UK) center of excellence for forensic next
May 8th, 2019 – Guilford, CT/Walnut Creek, CA – Medpricer, the leading purchased services cost management solution for the health care industry, announced today that Texas Children’s
April 30, 2019 (Madison, WI): Nimble Therapeutics has begun operating as a standalone business after spinning out from F. Hoffmann La Roche (SIX: RO, ROG;
GUILFORD, CONN. AND WALNUT CREEK, CALIF. (PRWEB) APRIL 22, 2019 Medpricer, the leading purchased services cost management solution for the healthcare industry, announced today Intermountain Healthcare
Vancouver, British Columbia– Precision NanoSystems (PNI), a biotechnology company pioneering innovative solutions for the development of genetic nanomedicines used in oncology, rare disease and infectious